Rapid and Sensitive Detection of Shiga Toxin-Producing Escherichia coli from Nonenriched Stool Specimens by Real-Time PCR in Comparison to Enzyme Immunoassay and Culture

ABSTRACT Shiga toxin (Stx)-producing Escherichia coli (STEC) bacteria are a frequent cause of food-borne gastroenteritis, hemorrhagic colitis, and hemolytic uremic syndrome. Because antimicrobial agents are generally contraindicated in patients infected with STEC, a sensitive and specific diagnostic test with rapid turnaround is essential. Current culture methods may fail to detect non-O157 STEC. We evaluated a Stx gene real-time PCR assay using hybridization probes and the LightCycler instrument with 204 prospectively collected stool specimens, which were also tested for Stx by enzyme immunoassay (EIA) (ProSpecT STEC; Remel, Lenexa, KS) and by culturing on chromogenic agar (Chromagar O157; BD BBL, Sparks, MD). In addition, 85 archived stool specimens previously tested for Stx (by EIA) and/or E. coli O157:H7 (by culture) were tested by PCR. Sample preparation for PCR included mixing the stool in sterile water and extraction of nucleic acid using the MagNA Pure LC instrument (Roche Diagnostics). The PCR assay had 100% sensitivity and specificity compared to EIA and culture for specimens collected prospectively (4 of 204 specimens were positive) and compared to culture and/or EIA for archival specimens (42 of 85 specimens were positive). Both the EIA and PCR produced positive results from a specimen containing an O103 serotype STEC in the prospective specimens, and the PCR test detected three positive specimens that contained nonviable STEC in the archived specimens. The PCR assay demonstrated 100% sensitivity and specificity compared to EIA and/or culture and more rapid turnaround than either EIA or culture.

[1]  J. Rosenblatt,et al.  Comparison of Real-Time PCR for Detection of the tcdC Gene with Four Toxin Immunoassays and Culture in Diagnosis of Clostridium difficile Infection , 2008, Journal of Clinical Microbiology.

[2]  E. Boedeker,et al.  Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections , 2008, Current opinion in gastroenterology.

[3]  T. F. Smith,et al.  Quantitative real-time polymerase chain reaction for evaluating DNAemia due to cytomegalovirus, Epstein-Barr virus, and BK virus in solid-organ transplant recipients. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Y. V. van Duynhoven,et al.  Evaluation of 5'-nuclease and hybridization probe assays for the detection of shiga toxin-producing Escherichia coli in human stools. , 2007, Journal of microbiological methods.

[5]  F. Scheutz,et al.  Subtyping Method for Escherichia coli Shiga Toxin (Verocytotoxin) 2 Variants and Correlations to Clinical Manifestations , 2007, Journal of Clinical Microbiology.

[6]  C. Sears,et al.  The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  H. Karch,et al.  Enterohaemorrhagic Escherichia coli in human medicine. , 2005, International journal of medical microbiology : IJMM.

[8]  P. Tarr,et al.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome , 2005, The Lancet.

[9]  S. Tzipori,et al.  Antibody Therapy in the Management of Shiga Toxin-Induced Hemolytic Uremic Syndrome , 2004, Clinical Microbiology Reviews.

[10]  T. Cleary The role of Shiga-toxin-producing Escherichia coli in hemorrhagic colitis and hemolytic uremic syndrome. , 2004, Seminars in pediatric infectious diseases.

[11]  R. Thomson,,et al.  Evaluation of Performance and Potential Clinical Impact of ProSpecT Shiga Toxin Escherichia coli Microplate Assay for Detection of Shiga Toxin-Producing E. coli in Stool Samples , 2004, Journal of Clinical Microbiology.

[12]  A. Siitonen,et al.  Clinical Escherichia coli Strains Carrying stx Genes: stx Variants and stx-Positive Virulence Profiles , 2002, Journal of Clinical Microbiology.

[13]  C. Park,et al.  Importance of Testing Stool Specimens for Shiga Toxins , 2002, Journal of Clinical Microbiology.

[14]  S. Kehl Role of the Laboratory in the Diagnosis of Enterohemorrhagic Escherichia coli Infections , 2002, Journal of Clinical Microbiology.

[15]  N. W. Davis,et al.  Genome sequence of enterohaemorrhagic Escherichia coli O157:H7 , 2001, Nature.

[16]  M. Louie,et al.  PCR Detection of Escherichia coli O157:H7 Directly from Stools: Evaluation of Commercial Extraction Methods for Purifying Fecal DNA , 2000, Journal of Clinical Microbiology.

[17]  Craig S. Wong,et al.  The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. , 2000, The New England journal of medicine.

[18]  A. Caprioli,et al.  A New Shiga Toxin 2 Variant (Stx2f) fromEscherichia coli Isolated from Pigeons , 2000, Applied and Environmental Microbiology.

[19]  S. Lauwers,et al.  Identification of New Verocytotoxin Type 2 Variant B-Subunit Genes in Human and Animal Escherichia coliIsolates , 1998, Journal of Clinical Microbiology.

[20]  K. Bettelheim Reliability of CHROMagar® O157 for the detection of enterohaemorrhagic Escherichia coli (EHEC) O157 but not EHEC belonging to other serogroups , 1998, Journal of applied microbiology.

[21]  B. Souweine,et al.  Non-O157:H7 Stx2-Producing Escherichia coli Strains Associated with Sporadic Cases of Hemolytic-Uremic Syndrome in Adults , 1998, Journal of Clinical Microbiology.

[22]  S. Ostroff,et al.  Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. , 1989, The Journal of infectious diseases.

[23]  Laboratory-confirmed non-O157 Shiga toxin-producing Escherichia coli--Connecticut, 2000-2005. , 2007, MMWR. Morbidity and mortality weekly report.

[24]  Ongoing multistate outbreak of Escherichia coli serotype O157:H7 infections associated with consumption of fresh spinach--United States, September 2006. , 2006, MMWR. Morbidity and mortality weekly report.

[25]  Importance of culture confirmation of shiga toxin-producing Escherichia coli infection as illustrated by outbreaks of gastroenteritis--New York and North Carolina, 2005. , 2006, MMWR. Morbidity and mortality weekly report.

[26]  A. Friedrich,et al.  Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. , 2002, The Journal of infectious diseases.

[27]  H. M.P.,et al.  Multistate outbreak of Escherichia coli O157:H7 infections associated with eating ground beef--United States, June-July 2002. , 2002, MMWR. Morbidity and mortality weekly report.

[28]  F. Jacobs,et al.  Hemolytic uremic syndrome in Belgium: incidence and association with verocytotoxin-producing Escherichia coli infection. , 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[29]  J. Paton,et al.  Detection and characterization of Shiga toxigenic Escherichia coli by using multiplex PCR assays for stx1, stx2, eaeA, enterohemorrhagic E. coli hlyA, rfbO111, and rfbO157. , 1998, Journal of clinical microbiology.

[30]  Update: multistate outbreak of Escherichia coli O157:H7 infections from hamburgers--western United States, 1992-1993. , 1993, MMWR. Morbidity and mortality weekly report.